ketorolac tromethamine has been researched along with Mouth Neoplasms in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (100.00) | 2.80 |
Authors | Studies |
---|---|
Botlagunta, M; Das Majumdar, SK; Dash, R; Muduly, DK; Panda, S; Priyadarshini, M; Rath, R; Samal, SK; Shriwas, O | 1 |
1 other study(ies) available for ketorolac tromethamine and Mouth Neoplasms
Article | Year |
---|---|
DDX3 modulates cisplatin resistance in OSCC through ALKBH5-mediated m
Topics: AlkB Homolog 5, RNA Demethylase; Animals; Antineoplastic Agents; Cell Death; Cell Line, Tumor; Cisplatin; DEAD-box RNA Helicases; Demethylation; Drug Resistance, Neoplasm; Forkhead Box Protein M1; Gene Expression Regulation, Neoplastic; Humans; Ketorolac Tromethamine; Mice; Mouth Neoplasms; Nanog Homeobox Protein; Neoplastic Stem Cells; RNA, Messenger; Squamous Cell Carcinoma of Head and Neck; Tumor Burden; Xenograft Model Antitumor Assays | 2020 |